Immediate Impact

1 by Nobel laureates 1 from Science/Nature 55 standout
Sub-graph 1 of 21

Citing Papers

Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials
2023 Standout
Pathogenesis of pneumonia and acute lung injury
2022 Standout
2 intermediate papers

Works of Barbara Lippert being referenced

Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany
2005

Author Peers

Author Last Decade Papers Cites
Barbara Lippert 122 16 3 71 47 29 283
Joel R. Campbell 33 7 76 32 26 242
Françoise Dreyfus 14 11 83 48 26 282
Brian Egan 13 3 52 51 28 330
Anne‐Laure Samson 21 58 18 23 43 28 298
Louisa Owens 66 29 18 38 108 28 327
Amy Pate 24 10 56 8 22 232
Christopher R. Reed 11 1 4 49 35 40 288
Miguel Rueda 106 25 5 8 19 210
Charulata Jindal 65 5 1 21 46 24 298
Matthew M Coates 25 33 45 79 16 21 318

All Works

Loading papers...

Rankless by CCL
2026